Literature DB >> 9857281

Probing lymphocyte biology by genomic-scale gene expression analysis.

A Alizadeh1, M Eisen, D Botstein, P O Brown, L M Staudt.   

Abstract

The identity and abundance of mRNA species within a cell dictate, to a large extent, the biological potential of that cell. Although posttranscriptional mechanisms modify protein expression in critical ways, cellular differentiation requires key changes in gene transcription, as evidenced by the potent phenotypes that result from disruption of transcription factor genes in mice. It is now possible to assess the mRNA profile of a cell globally using recently developed genomics techniques. This review focuses on the potential of cDNA microarrays to define gene expression in lymphoid cells, a field which is in its infancy. Examples of cellular activation genes and cytokine inducible genes discovered using this technology are presented but these represent only a taste of the fruit that this new technology will ultimately bear. Gene expression profiles should provide essential new insights into lymphocyte differentiation and activation, the pathogenesis of immune disorders, and the molecular abnormalities in lymphoid malignancies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9857281     DOI: 10.1023/a:1023293621057

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  31 in total

1.  Multiplexed biochemical assays with biological chips.

Authors:  S P Fodor; R P Rava; X C Huang; A C Pease; C P Holmes; C L Adams
Journal:  Nature       Date:  1993-08-05       Impact factor: 49.962

2.  A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization.

Authors:  D Shalon; S J Smith; P O Brown
Journal:  Genome Res       Date:  1996-07       Impact factor: 9.043

Review 3.  Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link.

Authors:  K S Ullman; J P Northrop; C L Verweij; G R Crabtree
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

4.  Genomics and human disease--variations on variation.

Authors:  P O Brown; L Hartwell
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

Review 5.  Pieces of the puzzle: expressed sequence tags and the catalog of human genes.

Authors:  G D Schuler
Journal:  J Mol Med (Berl)       Date:  1997-10       Impact factor: 4.599

6.  New opportunities for uncovering the molecular basis of cancer.

Authors:  R L Strausberg; C A Dahl; R D Klausner
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

7.  Yeast microarrays for genome wide parallel genetic and gene expression analysis.

Authors:  D A Lashkari; J L DeRisi; J H McCusker; A F Namath; C Gentile; S Y Hwang; P O Brown; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

8.  Quantitative monitoring of gene expression patterns with a complementary DNA microarray.

Authors:  M Schena; D Shalon; R W Davis; P O Brown
Journal:  Science       Date:  1995-10-20       Impact factor: 47.728

9.  TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL.

Authors:  G R Screaton; J Mongkolsapaya; X N Xu; A E Cowper; A J McMichael; J I Bell
Journal:  Curr Biol       Date:  1997-09-01       Impact factor: 10.834

10.  Characterization of human E4BP4, a phosphorylated bZIP factor.

Authors:  W J Chen; K S Lewis; G Chandra; J P Cogswell; S W Stinnett; S H Kadwell; J G Gray
Journal:  Biochim Biophys Acta       Date:  1995-12-27
View more
  14 in total

Review 1.  Gene expression profiling of lymphomas.

Authors:  U Hegde; W H Wilson
Journal:  Curr Oncol Rep       Date:  2001-05       Impact factor: 5.075

2.  Activation changes the spectrum but not the diversity of genes expressed by T cells.

Authors:  T K Teague; D Hildeman; R M Kedl; T Mitchell; W Rees; B C Schaefer; J Bender; J Kappler; P Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

3.  Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis.

Authors:  M Srivastava; O Eidelman; H B Pollard
Journal:  Mol Med       Date:  1999-11       Impact factor: 6.354

Review 4.  Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics.

Authors:  Romain Banchereau; Alma-Martina Cepika; Jacques Banchereau; Virginia Pascual
Journal:  Annu Rev Immunol       Date:  2017-01-30       Impact factor: 28.527

5.  Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival.

Authors:  A N Jain; K Chin; A L Børresen-Dale; B K Erikstein; P Eynstein Lonning; R Kaaresen; J W Gray
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 6.  Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.

Authors:  Kian-Huat Lim; Yibin Yang; Louis M Staudt
Journal:  Immunol Rev       Date:  2012-03       Impact factor: 12.988

7.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.

Authors:  C M Perou; S S Jeffrey; M van de Rijn; C A Rees; M B Eisen; D T Ross; A Pergamenschikov; C F Williams; S X Zhu; J C Lee; D Lashkari; D Shalon; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

8.  Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.

Authors:  R Renne; C Barry; D Dittmer; N Compitello; P O Brown; D Ganem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

9.  Gene expression patterns in ovarian carcinomas.

Authors:  Marci E Schaner; Douglas T Ross; Giuseppe Ciaravino; Therese Sorlie; Olga Troyanskaya; Maximilian Diehn; Yan C Wang; George E Duran; Thomas L Sikic; Sandra Caldeira; Hanne Skomedal; I-Ping Tu; Tina Hernandez-Boussard; Steven W Johnson; Peter J O'Dwyer; Michael J Fero; Gunnar B Kristensen; Anne-Lise Borresen-Dale; Trevor Hastie; Robert Tibshirani; Matt van de Rijn; Nelson N Teng; Teri A Longacre; David Botstein; Patrick O Brown; Branimir I Sikic
Journal:  Mol Biol Cell       Date:  2003-09-05       Impact factor: 4.138

10.  Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.

Authors:  Ellen D Cahir-McFarland; Kara Carter; Andreas Rosenwald; Jena M Giltnane; Sarah E Henrickson; Louis M Staudt; Elliott Kieff
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.